Sanofi

News

SCOTUS ruling on PCSK9 could rewrite status quo on patents

On the face of it, the battle between Amgen and Sanofi/Regeneron being heard in the US Supreme Court is a mundane biopharma contest over rights and royalties on PCSK9 inhi

News

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.

News

Dupixent works in hard-to-treat form of atopic dermatitis

IL-4 inhibitor shows its worth in atopic hand-foot dermatitis unresponsive to corticosteroids.

News

Sanofi cuts price of Lantus insulin in US by 78%

Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.

News

Sanofi buys Provention and diabetes drug Tzield for $2.9bn

T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.

News

Sanofi sings a song for rare disease and equitable care

'This is Rare' campaign sings the plight of the rare disease community this awareness day.

SCOTUS ruling on PCSK9 could rewrite status quo on patents

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

Dupixent works in hard-to-treat form of atopic dermatitis

Sanofi cuts price of Lantus insulin in US by 78%

Sanofi buys Provention and diabetes drug Tzield for $2.9bn

Sanofi sings a song for rare disease and equitable care

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Sanofi

Editor's Picks